KYMR
Kymera Therapeutics Inc.
Company Overview
| Mkt Cap | $4.43B | Price | $61.84 |
| Volume | 485.99K | Change | +0.65% |
| P/E Ratio | -19.8 | Open | $60.60 |
| Revenue | $47.1M | Prev Close | $61.44 |
| Net Income | $-223.9M | 52W Range | $19.45 - $63.96 |
| Div Yield | N/A | Target | $67.09 |
| Overall | 63 | Value | 60 |
| Quality | 63 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyKymera Therapeutics Inc. (KYMR) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $61.84 with a market capitalization of $4.43 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows KYMR with a volume of 486K shares. The stock opened down 1.37% from yesterday's close of $61.44. Current analyst estimates project earnings of $-3.28 per share for this year, with next year targeting $-3.92.
KYMR demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for KYMR include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 8.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:41 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $61.84 | +0.7% | 485.99K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW